To evaluate outcomes after implementing the women's health assessment tool (WHAT) and clinical decision support toolkit during annual well-women visits. Methods: An observational project involved women aged 45-64 years attending one of three medical sites in Washington (WA, USA). Responses to the WHAT questionnaire and patients' health resource utilization prepost toolkit implementation were analyzed. Results: A total of 110 women completed the WHAT questionnaire. Majority of women were postmenopausal (77.3%) and experienced depressive mood (63.6%), hot flashes (61.8%) or anxiety (60.9%) in the last 3 months. There was a 72.2% increase in the number of diagnoses made during the annual visit versus the previous 12 months.
Background
As women enter mid-life, aged 45-64 years, many experience hormonal changes related to menopause transition resulting in new health issues. Some of the most common conditions among mid-life women include vasomotor symptoms (VMS), vulvovaginal atrophy (VVA), urinary incontinence (UI) and depression; with prevalence rates ranging from 10-80% of women [1] [2] [3] [4] . Women can also suffer from other negative consequences associated with these conditions such as increased anxiety, sexual dysfunction and increased stress which can have a significant impact on women's health and overall health-related quality of life [4, 5] .
Despite the prevalence and impact of these conditions on mid-life women, research has shown that the healthcare needs of mid-life women are often overlooked or underprioritized due to other healthcare concerns in busy clinical practices [4, 6] . One study found that only 30% of women aged 40-64 years reported seeking healthcare for their menopausal symptoms within the last 12 months [7] . Additionally, the infrequency of patient visits and the expansive list of topics to cover present doctors with challenges in prioritization during a patient's annual visit [8] . Computer-based instruments linked to electronic health record (EHR) systems such as computer-based clinical decision support (CDS) or online assessment tools have been developed and implemented in primary care to address these issues and have been shown to improve delivery of care and patient outcomes [9] [10] [11] .
Given that mid-life women, aged 45-64 years, comprise the largest and fastest-growing population segment in the USA [12, 13] , an electronic health assessment instrument, the women's health assessment tool (WHAT)/ CDS toolkit, was recently developed to address these issues in the care of mid-life women (45-64 years of age). The WHAT/CDS toolkit is comprised of two components. The first is the WHAT, a 35-item Outcomes of implementing the women's health assessment tool and clinical decision support toolkit future science group Short Communication Silvestrin, Steenrod, Coyne et al.
patient self-reported questionnaire that assesses health conditions relevant to mid-life women. The WHAT questionnaire uses both existing measures and newly developed questions to evaluate highly prevalent symptoms such as hot flashes, depressive mood, anxiety, sexual dysfunction, vaginal dryness, bladder problems and breast pain which are commonly linked to diagnoses of UI, depression, VVA and VMS. Three previously validated measures that are included in the WHAT: the patient health questionnaire-9 (PHQ-9), the generalized anxiety disorder-2 (GAD-2) scale, 3 incontinence questions (3IQ), as well as a few questions from the female sexual function index-6 item (FSFI-6) [14] [15] [16] [17] . The WHAT is administered through MyChart, an Epic Systems Corporation (WI, USA) patient portal of the EHR systems.
The second component of the WHAT/CDS toolkit is the CDS toolkit. The CDS toolkit is built within the EHR that support delivery of evidence-based care and shared decision-making. The CDS toolkit is comprised of condition-based components called SmartSets which provide information on diagnoses, laboratory tests, procedures/diagnostic tests, referrals and patient instructions/information as well as best practice alerts, which alert providers of additional questions to consider based on the patient's responses to the WHAT questionnaire. In addition, relevant information from the EHR including prior history, laboratories, imaging studies, reports in the form of discrete data or links to a section in the EHR are generated for the provider.
The main purpose of this pilot project was to evaluate the outcomes of implementing the WHAT/CDS toolkit at three clinical sites of an integrated delivery network (IDN) in Washington state through analysis of the responses to the WHAT questionnaire and EHR data collected from the WHAT/CDS toolkit. A secondary objective of this pilot project was to compare patients' diagnosis and health resource utilization (HRU) including tests, procedures, referral and followup visits 1 year before and after the implementation of the WHAT/CDS toolkit.
Methods
This was a prospective data collection pilot project involving mid-life women who attended one of the three participating clinical sites of the IDN serving communities in the South Puget Sound area of Washington state. To be eligible for participation, women were required to be existing 45-64-year-old female patients and registered MyChart users who were scheduled for an annual well-woman visit between 1 March and 31 July 2014. This pilot project was reviewed and approved by the Institutional Review Board of the participating IDN prior to patient recruitment and data collection.
Data collection
Eligible women were informed of the pilot project when scheduling their annual well-woman visit. They were then sent an email through their MyChart patient portal 1 week prior to their scheduled annual visit asking them to complete the WHAT questionnaire online. Women who had not completed the WHAT questionnaire 48 h prior to their scheduled well-woman visit received a reminder email at that time. Upon opening the WHAT, the first screen was an informed consent detailing the purpose and objectives of the pilot project. Each patient had to provide consent to participate before being allowed to proceed to the WHAT questionnaire.
After completing the WHAT questionnaire, the responses were directly uploaded to the patient's EHR and were available for review by their healthcare provider prior to their well-woman visit. During the wellwoman visit, relevant data from EHR such as previous diagnoses or laboratory tests and SmartSets, which provided a list of relevant action steps associated with a specific condition, were available to providers. Best practice alerts were also triggered during the patient's annual well-woman visit based on the responses to the WHAT questionnaire. All data collected through the CDS toolkit were also imbedded into the patients' EHR.
At the conclusion of the data collection period, a retrospective analysis of EHR data collected during the well-woman visit and the 12 months prior to the patient's well-woman visit was conducted for patients who completed the WHAT. The analysis intended to assess changes in patients' HRU, namely diagnoses, diagnostic tests and procedures, laboratory tests and referrals, before and after the implementation of WHAT/CDS toolkit. The patients' HRU focused on comparing patients' diagnosis, diagnostic tests/procedures, laboratory tests and follow-up visits. Figure 1 provides an overview of the data collection process.
Data analysis
All analyses were conducted using SAS version 9.4 [18] . Descriptive summary statistics (n, percentage, mean, standard deviation [SD] or range, as appropriate) were used to characterize the patient sociodemographic and clinical characteristics. Descriptive statistics were also used to examine the WHAT questionnaire responses and HRU data collected during the annual well-woman visit. The PHQ-9, GAD-2 and 3IQ were scored using the scoring algorithm for each instrument. Conditionspecific (UI, depression, VVA and VMS) analyses were conducted for all HRU data. If patients had more than one diagnosis (e.g., UI and VMS), the HRU would be counted in both diagnosis tables as it was not possible to discern which condition the resource was attributable. Changes in HRU parameters such as diagnoses, Outcomes of implementing the women's health assessment tool & clinical decision support toolkit Short Communication referrals and follow-up visits from the prior year's visit to the current annual well-woman visit were analyzed using descriptive statistics (n, percentage). No missing data were imputed.
Results
Over the recruitment period, 370 women were asked to participate in the pilot project with 110 completing the WHAT questionnaire (29.7% response rate). Women mean age was 54.3 years (SD: 5.9; range: 45-64 years); the majority were white (90.0%) (Table 1 ). Prior to their well-woman visit, the women's most common comorbid conditions included diseases of the musculoskeletal system and connective tissue such as osteoarthritis and joint pain. This was followed by endocrine, nutritional and metabolic diseases, immunity disorders and gynecological diseases of the genitourinary tract (Table 1 ).
Responses to the WHAT questionnaire
Among women completing the questionnaire, the majority of patients were postmenopausal (77.3%). For women who still had their period, most had noticed a change in the last 12 months (60.0%) ( Table 2) . Overall, the majority of women rated their overall health as at least 'good' (88.2%) and roughly, half of the women indicated that they 'sometimes' felt overwhelmed by stress.
All women were then asked information on their experience with seven health conditions including hot flashes, depressive mood, anxiety, sexual problems, dryness or discomfort of the vagina, bladder problems and breast pain. Nearly a third of the women (31.8%) did not experience any of the conditions. The remaining women indicated that they had experienced some level of hot flashes (61.8%), depressive mood (63.6%) or anxiety (60.9%) in the last 3 months. About half indicated that they had experienced some level of sexual problems (46.4%), dryness or discomfort of the vagina (50.0%) or bladder problems (55.5%). The majority of women (77.3%) indicated that they had not experienced breast pain.
Of patients who experienced hot flashes of moderate or greater severity (25.5%), most experienced 6 or less per day (82.2%). Women who reported at least mild depressive mood (63.6%) completed the PHQ-9 with a mean score of 5.9 (SD: 4.9) and scores ranging from 0 (indicating no depression) to 23 (indicating severe depression). Likewise, women who experienced mild anxiety or greater (60.9%) completed the GAD-2, with a mean score of 1.7 (SD: 1.4) and scores ranging from 0 (indicating no anxiety) to 6 (indicating severe anxiety). The majority of women who reported sexual dysfunction with moderate or greater severity (24.5%) reported being 'somewhat' (37.0%) or 'a lot' (33.3%) bothered by the condition.
At the conclusion of the WHAT questionnaire, women who had experienced at least one condition, were asked to rank their condition(s) according to which they considered to be the most bothersome and to impact their lives the most on a daily basis. Anxiety (22.7%) was considered the most bothersome followed future science group Short Communication Silvestrin, Steenrod, Coyne et al. by depression (13.6%), bladder problems (11.8%) and hot flashes (9.1%).
Diagnosis & HRU before & after the WHAT/CDS toolkit implementation
After the implementation of the WHAT/CDS toolkit, a third of the women (n = 37) had at least one current diagnosis of the four conditions assessed (UI, VVA, depression and VMS) during the well-woman visit ( Table 3 ). The most common diagnosis at the well-woman visit among the four conditions was VMS (total VMS cases: n = 16). There were 31 new diagnoses made during the well-woman visit, representing a 72.2% change in the diagnoses rate compared with the visits from 12 months prior (previous 12 month diagnoses: n = 18).
For all four conditions being analyzed, there was an increase in the number of new diagnoses made during the well-woman visit compared with the previous 12 months. VMS had the greatest number of new diagnoses during the well-woman visit (n = 15) when compared with the previous 12 months (n = 7). There were similar increases in VVA and depression diagnoses during the well-woman visit (VVA: n = 11; depression: n = 9) compared with the previous 12 months (VVA: n = 7; depression: n = 4) while UI diagnoses had the smallest changes (previous 12 months diagnoses: n = 3, new diagnoses during the well-woman visit: n = 4). There was a slight increase in the number of new referrals made during the well-woman visit (n = 9) compared with the previous 12 months (n = 5) and the most common referrals were for behavioral health (n = 2) or endocrinology (n = 2).
After the implementation of the WHAT/CDS toolkit, the number of laboratory tests ordered during the well-woman visit increased for patients diagnosed with UI (n = 16) and VVA (n = 17) compared with the previous 12 months (UI: n = 10; VVA: n = 5) while decreasing among patients diagnosed with VMS during the well-woman visit (n = 7) compared with the previous 12 months (n = 12) ( Table 4 ). The number of laboratory tests ordered through the CDS toolkit during the well-woman visit ranged from 1 to 5 for individuals diagnosed with UI, depression, VVA and VMS.
The number of procedures or diagnostic tests ordered through the CDS toolkit during the well-woman visit were same from the previous 12 months for patients diagnosed with UI (n = 2) or VMS (n = 13) (Table 5 ). However, there was a substantial increase in the number of procedures/diagnostic tests ordered among women diagnosed with VVA during the well-woman visit (n = 17) compared with the previous 12 months (n = 5). The procedures or diagnostic tests ordered through the CDS toolkit during the well-woman visit ranged from 1 to 10 among patients diagnosed. Outcomes of implementing the women's health assessment tool & clinical decision support toolkit Short Communication
Discussion
The annual well-woman visit can play a vital role in the maintenance of women's health and becomes increasingly more important as women enter middle age given they experience a number of new health issues [19] . Unfortunately, with so many competing priorities of family, work and life, many of these conditions are ignored or overshadowed by other conditions which results in missed diagnoses [4] . The WHAT/ CDS toolkit was designed to serve as a resource to healthcare providers to assist in the assessment of high prevalence diagnoses among women in mid-life. This pilot project aimed to evaluate the health status of mid-life women as well as HRU outcomes associated with the implementation of the WHAT/ CDS toolkit. Results from the WHAT questionnaire showed that nearly 70% of women experienced at least mild severity of one of the symptoms assessed through the WHAT questionnaire demonstrating the relevance of the questionnaire and reflecting prevalence rates consistent with other studies of mid-life women [1, 4, 5, 20] . Depressive mood was the most commonly reported symptom captured in the WHAT questionnaire which supports other findings that women were more likely to experience a major depressive episode when they were perimenopausal or early postmenopausal [21] . Likewise, a systematic review of studies implementing assessment tools into primary care found better detection and reporting of mental health issues by patients compared with other primary care concerns [22] . Interestingly, there were only three new behavioral health/psychiatric referrals for this patient cohort. Given the prevalence or reported anxiety and depression, this may or may not be an underutilization of services depending upon the needs of the patients. It should be recognized that the well-woman visit is a primary opportunity for such referrals depending upon patient needs.
While management of chronic diseases such as cancer and diabetes have implemented electronic management tools similar to what is in the WHAT/CDS toolkit, there is limited research on the implementation and impact of condition-specific instruments within women's health [10, 11] . The results from the well-woman visit show an increase in the number of diagnoses and laboratory tests ordered across all four assessed conditions during the visit compared with the previous 12 months. However, since this pilot project is cross sectional, it is not known whether the increase in the diagnoses is due to the increased attention to these conditions by the implementation of the WHAT questionnaire or due to the new development of these conditions. Future longitudinal research is needed to address this question.
The noted prevalence of the conditions observed in this pilot project indicates that the use of a patient self-reported questionnaire may provide a mechanism to identify patient conditions that may be Outcomes of implementing the women's health assessment tool & clinical decision support toolkit Short Communication missed during clinical visits. This is increasingly important in a time when primary care doctors have a multitude of content to cover and limited guidance in doing so [8] . Additionally, our participation rate shows that the women were willing to complete questionnaires about their health prior to their annual well-woman visit. This may be attributed to the fact that the WHAT questionnaire allowed women to complete the questionnaire in the privacy of their home at a time convenient to them which has been found to improve a patient's willingness to report issues that are embarrassing or sensitive, such as sexual functioning or vaginal dryness [23] [24] [25] . The WHAT questionnaire was also intended to minimize patient burden by requiring patients to complete only questions that are relevant based on a preliminary assessment of their symptoms. Evaluations of similar questionnaires in a primary care setting have shown that information feedback to providers from individual-focused questionnaires benefits provider diagnosis and management of patient conditions [22] . These benefits along with focusing patient-provider communication can help increase efficiencies within clinical practice and can be an incentive for providers to participate in the adoption of such integrated tools. Additionally, a review by Boyce and Browne found that these types of instruments are most effective when implemented in an outpatient population, such as primary care [26] .
Strengths
The WHAT questionnaire covered symptoms and conditions relevant to mid-life women. The implementation of the WHAT questionnaire through a webbased portal enabled patients to complete the questionnaire prior to their well-woman visit and enabled healthcare providers to access and integrate the patient responses into the visit. Although a control group was not used in this project, having access to the retrospective data allowed for a historical comparison of diagnoses and HRU made before and after the WHAT/CDS implementation.
Limitations
Given that recruitment of patients was conducted within three clinical sites of one healthcare system in the northwest, the results cannot be generalized to other clinical sites and other IDNs. Additionally, generalizability is limited as only 30% of women invited to the project actually participated. This response rate may be due to the following reason.
Having patients completing a health questionnaire at home prior to a primary care visit/gynecology visit is a relatively new practice procedure and was new for this IDN. Given that, there may be a lack of awareness of the invite since all invitations had only been sent via email. The use of MyChart and email as a patient communication portal for such health assessment tools needs further exploration and refinement.
There was a lack of diversity (90% white) among the participants although there was an even distribution of mid-life ages. The majority of patients were recruited from the Women's health site, not from the two primary care centers, which may have biased the results.
Given the cross-sectional nature of this pilot project and lack of control group, it is impossible to infer any causal relationship between the WHAT/CDS toolkit and the changes in diagnosis and HRUs. Finally, the benefits from the implementation of the WHAT/ CDS toolkit suggest improvements in the delivery of care; however, success is heavily reliant on the adaption of the toolkit into routine practice. A successful adaption requires full engagement of hospital staff and resources (e.g., IT infrastructure). Some healthcare systems may lack such capacity to integrate the WHAT/CDS toolkit.
Conclusion
The WHAT questionnaire covers the conditions relevant to mid-life women. An increase across all four assessed conditions in the number of diagnoses made during the well-woman visit after the implementation of the WHAT/CDS toolkit was observed. The use of the WHAT may provide a way to identify conditions that may be missed during clinical visits among the middle-aged women. This was a pilot project to evaluate the WHAT/CDS toolkit therefore, additional research should be conducted at more clinical sites over a long-term period with an inclusion of control group to better assess how the implementation of the WHAT/CDS toolkit can impact patient outcomes.
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Executive summary
Background
• Research has shown that the healthcare needs of mid-life women are often overlooked or underprioritized due to other healthcare concerns in busy clinical practices. • The women's health assessment tool (WHAT)/clinical decision support (CDS) toolkit, was developed to capture highly prevalent conditions in mid-life women (45-64 years of age). • The WHAT/CDS toolkit combined a patient completed questionnaire with a clinical decision support system built within the electronic health record (EHR) that support delivery of evidence-based care and shared decision-making.
Methods
• The pilot project evaluated the outcomes of implementing the WHAT/CDS toolkit at three clinical sites of an integrated delivery network in Washington state through analysis of the responses to the WHAT questionnaire and electronic health record data collected from the WHAT/CDS toolkit.
Results
• The WHAT/CDS toolkit was implemented for 4 months and had a 30% response rate (n = 110 women participated). • Nearly 70% of women experienced at least mild severity of one of the seven symptoms assessed through the WHAT questionnaire. • When using the WHAT, there was an increase in the number of diagnoses and laboratory tests ordered across all four assessed conditions during the well-woman visit compared with the previous 12 months.
Conclusion
• The use of a patient self-reported questionnaire, like the WHAT questionnaire, may provide a mechanism to identify patient conditions that may be missed during clinical visits.
